Xin Lang Cai Jing·2025-10-09 05:38Group 1 - The stock of Yipinhong Pharmaceutical Group Co., Ltd. fell by 5.01% to 56.45 CNY per share, with a trading volume of 312 million CNY and a turnover rate of 1.29%, resulting in a total market capitalization of 25.498 billion CNY [1] - Yipinhong was established on February 4, 2002, and listed on November 16, 2017. The company focuses on the research, production, and sales of its own pharmaceuticals, as well as the sales of agency drugs [1] - The main revenue composition of Yipinhong includes children's medicine at 61.12%, chronic disease medicine at 22.71%, and other products at 16.17% [1] Group 2 - Citic Securities Fund has one fund heavily invested in Yipinhong, specifically the Citic Securities Vision Return A (011868), which held 95,000 shares in the second quarter, accounting for 0.91% of the fund's net value [2] - The fund has experienced a floating loss of approximately 283,100 CNY today, with a total fund size of 430 million CNY and a year-to-date return of 28.63% [2] - The fund's performance ranks 3650 out of 8238 in its category this year, and it has a one-year return of 29.3%, ranking 3143 out of 8082 [2] Group 3 - The fund manager of Citic Securities Vision Return A is Xie Wei, who has been in the position for 7 years and 129 days, managing a total fund size of 1.987 billion CNY [3] - During Xie Wei's tenure, the best fund return was 106.5%, while the worst return was -20.05% [3]